DOK7 myasthenic syndrome with subacute adult onset during pregnancy and partial response to fluoxetine

•DOK7 congenital myasthenic syndrome (CMS) presenting in a 39-year old woman.•The disease presented during pregnancy and was first diagnosed as myasthenia gravis.•Consider CMS before adult-onset generalized seronegative myasthenic syndromes.•Worsening muscle weakness under anticholinesterase inhibit...

Full description

Saved in:
Bibliographic Details
Published inNeuromuscular disorders : NMD Vol. 28; no. 3; pp. 278 - 282
Main Authors Santos, Mariana, Cruz, Simão, Peres, João, Santos, Luís, Tavares, Purificação, Basto, Jorge Pinto, Salgado, Vasco, Valverde, Ana Herrero
Format Journal Article
LanguageEnglish
Published England Elsevier B.V 01.03.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:•DOK7 congenital myasthenic syndrome (CMS) presenting in a 39-year old woman.•The disease presented during pregnancy and was first diagnosed as myasthenia gravis.•Consider CMS before adult-onset generalized seronegative myasthenic syndromes.•Worsening muscle weakness under anticholinesterase inhibitors.•Novel report of a clear beneficial effect of fluoxetine in DOK7-CMS. DOK7 congenital myasthenic syndrome (DOK7-CMS) generally presents early in life and is treated with salbutamol or ephedrine. This report describes an atypical case of a 39-year-old woman who presented with proximal upper limb weakness in the third trimester of pregnancy and was initially diagnosed with seronegative myasthenia gravis. Dramatic clinical worsening under pyridostigmine and further inefficacy of steroids, intravenous human immunoglobulin (IVIG) and plasma exchange (PLEX) led to the presumptive diagnosis of a CMS. Initially, a slow-channel CMS was regarded as more probable due to prominent finger extension weakness. Accordingly, fluoxetine was started and a lengthy improvement was seen. Clinical deterioration occurred after fluoxetine withdrawal, when a c.1124_1127dup homozygous mutation was detected in DOK7 gene. Afterwards, salbutamol was started and the patient became asymptomatic. This case highlights the importance of considering CMS before an adult-onset myasthenic syndrome and suggests a benefit from fluoxetine not previously reported in DOK7-CMS.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0960-8966
1873-2364
DOI:10.1016/j.nmd.2017.12.005